KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bionano Genomics (BNGO) Tax Provisions (2017 - 2025)

Historic Tax Provisions for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to $14000.0.

  • Bionano Genomics' Tax Provisions fell 4166.67% to $14000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $32000.0, marking a year-over-year increase of 90000.0%. This contributed to the annual value of $33000.0 for FY2024, which is 4677.42% down from last year.
  • Per Bionano Genomics' latest filing, its Tax Provisions stood at $14000.0 for Q3 2025, which was down 4166.67% from $10000.0 recorded in Q2 2025.
  • In the past 5 years, Bionano Genomics' Tax Provisions ranged from a high of $1.8 million in Q4 2022 and a low of -$5.8 million during Q4 2021
  • Moreover, its 5-year median value for Tax Provisions was $14000.0 (2025), whereas its average is -$195157.9.
  • As far as peak fluctuations go, Bionano Genomics' Tax Provisions tumbled by 5232727.27% in 2021, and later soared by 35555.56% in 2022.
  • Bionano Genomics' Tax Provisions (Quarter) stood at -$5.8 million in 2021, then soared by 131.3% to $1.8 million in 2022, then tumbled by 101.99% to -$36000.0 in 2023, then surged by 102.78% to $1000.0 in 2024, then surged by 1300.0% to $14000.0 in 2025.
  • Its Tax Provisions was $14000.0 in Q3 2025, compared to $10000.0 in Q2 2025 and $7000.0 in Q1 2025.